Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.
about
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisAntibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisAntibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisAn adult cystic fibrosis patient presenting with persistent dyspnea: case report.Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessusMulticenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyThe changing microbial epidemiology in cystic fibrosis.Mycobacteriophage-drived diversification of Mycobacterium abscessus.Clinical significance of microbial infection and adaptation in cystic fibrosis.Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patientsMycobacterium abscessus multispacer sequence typing.Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Pulmonary Tuberculosis in a Patient with Cystic FibrosisPrevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France.Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center.Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implicationsAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.Tuberculosis reinfection in a pregnant cystic fibrosis patient.Approaches to analyse dynamic microbial communities such as those seen in cystic fibrosis lung.Non-tuberculous mycobacterial infections.Mycobacterium abscessus: an emerging rapid-growing potential pathogen.Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.Acute respiratory failure involving an R variant of Mycobacterium abscessusMycobacterium abscessus pneumonia in an Atlantic bottlenose dolphin (Tursiops truncatus).Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisCurrent dilemmas in antimicrobial therapy in cystic fibrosis.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Mycobacteria causing human cervical lymphadenitis in pastoral communities in the Karamoja region of Uganda.Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities.Effect of amikacin on cell wall glycopeptidolipid synthesis in Mycobacterium abscessus.Vaccine strategies against cystic fibrosis pathogens.Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
P2860
Q24187458-F84BB61C-0239-45EE-8DBB-BFACBB36319DQ24202353-8E866CC5-B30E-4770-A9FA-2BD696DA2FEEQ24202502-51BFCAF1-4FD7-4041-BF2A-0FC9CB36973FQ33242732-EFC74E73-EFA9-4BCA-938C-5DA35B9074C5Q33471490-26C58B1C-97FC-48A6-AFC5-011DFCFC8610Q33511706-C7154D1F-C93F-435C-9C43-D9F7F297B5ADQ33697276-7E41BD6E-9568-467D-A266-C652B68D0FE8Q33825634-BD36D5FB-3168-4493-8BF4-5B11B111EDF5Q34231400-078F830D-6DF5-47C6-BD21-6C02EBBCF626Q34491552-F2085ECB-F38A-4EBA-9566-0A38F6FBC426Q34537770-2226E083-5E12-4D4A-AE81-A368A1AB1CE4Q34538162-2176F697-EA4B-4A3B-8F06-030EE6324323Q34610992-0C920C3D-86B7-4BDA-B8F2-FF82399F0F13Q35124580-86464A1B-E864-4496-9550-3C34911A9352Q35717054-63E0F5FA-BBC9-4EB5-8CAB-8B3901A89BB9Q35822245-985E6FDB-E939-4B31-A357-C853AA214D97Q35904881-AC25A109-5DDE-48C6-8F21-8A71E9711060Q35925603-6A00AE28-A5A8-4C36-B8C5-9743518F2930Q36156072-D95824BE-9F1C-48B4-86D3-DED2935AF40DQ36184296-9403670F-70F1-472E-9587-8BCB83F36243Q36378866-4DB2B6FC-C4BC-4438-B5A6-BDAC139678B4Q36405440-F0A370D8-9FF7-4FDF-8818-E58D03B58D75Q36482309-62D80BD6-1E88-47B2-8BF4-E3C2E4A5F042Q36489352-EF84C635-9D14-47DF-9CB3-644C12AEA3ACQ36688950-A6324302-8163-46B0-B03C-95A8C96CBCC3Q37051388-91A768CD-066F-4B16-B230-8BFA21076D66Q37243892-520EF91C-82FE-44A5-8199-471EC1B9362CQ37304358-4CB4476B-D56A-4AD1-9763-F5075515F895Q37334924-6E897314-3A88-432D-9901-F4971DAE1977Q37481693-016B5BDC-85A0-499A-AB4B-9C62E1633B23Q37640941-77C0FCFE-3B31-4112-8842-E6592FF3BED4Q37679780-9B9A0A23-4ED6-4974-B734-D2B24CA34F72Q38042719-3F3B924A-CF83-4732-98D0-C3BA0889B4A5Q38749090-6C90F70F-5DC4-4810-BD73-5213D1E18AE6Q38877829-E374440B-5F97-4E69-B59D-AC09AB678DD4Q39045755-5A5E1B60-EB0D-4808-BF00-5310C9CA2362Q39225829-38FF0633-D842-4A6C-8463-F253C2817262Q40116009-F2FFB90A-D2DE-4881-9909-59E50595B388Q40262035-4B87FAAA-528E-4757-97F6-88FD31804A4DQ40704655-B8BF6F75-3739-4BF7-ADC6-C7A9F98759E6
P2860
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Age-related prevalence and dis ...... patients with cystic fibrosis.
@ast
Age-related prevalence and dis ...... patients with cystic fibrosis.
@en
type
label
Age-related prevalence and dis ...... patients with cystic fibrosis.
@ast
Age-related prevalence and dis ...... patients with cystic fibrosis.
@en
prefLabel
Age-related prevalence and dis ...... patients with cystic fibrosis.
@ast
Age-related prevalence and dis ...... patients with cystic fibrosis.
@en
P2093
P2860
P50
P1476
Age-related prevalence and dis ...... patients with cystic fibrosis.
@en
P2093
Agnès Ferroni
Anne Munck
Brigitte Fauroux
Catherine Offredo
Catherine Pierre-Audigier
Edouard Bingen
Gilles Quesne
Hoang Vu-Thien
Isabelle Sermet-Gaudelus
Jean-Louis Gaillard
P2860
P304
P356
10.1128/JCM.43.7.3467-3470.2005
P407
P577
2005-07-01T00:00:00Z